Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry

Mistiri, Mufid El; Salati, Massimiliano; Marcheselli, Luigi; Attia, Adel; Habil, Salah; Alhomri, Faraj; Spika, Devon; Allemani, Claudia; Federico, Massimo

doi:10.1016/j.annepidem.2015.03.012

Cited by 31 publications

(32 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, adjuvant, neoadjuvant, endocrine or targeted therapies in low-resource countries are still gravely underutilized. The age-standardized, 5-year relative survival rate of breast cancer has increased to more than 90% in the United States[ 23 ], whereas the rate in Eastern Libya is still only 56%[ 24 ].…”

Section: Discussionmentioning

confidence: 99%

The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment

Lou

Tian

et al. 2016

PLoS ONE

View full text Add to dashboard Cite

Breast cancer is a worldwide threat to female health with patient outcomes varying widely. The exact correlation between global outcomes of breast cancer and the national socioeconomic status is still undetermined. Mortality-to-incidence ratio (MIR) of breast cancer was calculated with the contemporary age standardized incidence and mortality rates for countries with data available at GLOBOCAN 2012 database. The MIR matched national human development indexes (HDIs) and health system attainments were respectively obtained from Human Development Report and World Health Report. Correlation analysis, regression analysis, and Tukey-Kramer post hoc test were used to explore the effects of HDI and health system attainment on breast cancer MIR. Our results demonstrated that breast cancer MIR was inversely correlated with national HDI (r = -.950; P < .001) and health system attainment (r = -.898; P < .001). Countries with very high HDI had significantly lower MIRs than those with high, medium and low HDI (P < .001). Liner regression model by ordinary least squares also indicated negative effects of both HDI (adjusted R2 = .903, standardize β = -.699, P < .001) and health system attainment (adjusted R2 =. 805, standardized β = -.009; P < .001), with greater effects in developing countries identified by quantile regression analysis. It is noteworthy that significant health care disparities exist among countries in accordance with the discrepancy of HDI. Policies should be made in less developed countries, which are more likely to obtain worse outcomes in female breast cancer, that in order to improve their comprehensive economic strength and optimize their health system performance.

show abstract

Section: Discussionmentioning

confidence: 99%

The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment

Lou

Tian

et al. 2016

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…Because of early symptoms of uterine corpus cancer, early diagnosis and treatment is common in HICs, where 5-year survival is around 80% (82,83). Survival is lower in LMICs with less available health services and treatment; 5-year survival in Benghazi, Libya, is only 17% (84). In 2012, there were an estimated 1.2 million women worldwide who had received a diagnosis of uterine corpus cancer in the previous 5 years (4).…”

Section: Uterine Corpus Cancermentioning

confidence: 99%

“…The prognosis is generally even poorer in many other LMICs. For example, 5-year survival of 3% in men and women combined has been reported from Libya (84). In 2012, there were an estimated 626,000 women alive worldwide who had a lung cancer diagnosis within the previous 5 years (4).…”

Section: Lung Cancermentioning

confidence: 99%

Global Cancer in Women: Burden and Trends

Torre

Islami

Siegel

et al. 2017

Cancer Epidemiology, Biomarkers &Amp; Prevention

953

728

View full text Add to dashboard Cite

There are striking disparities in the global cancer burden in women, yet few publications highlight cancer occurrence in this population, particularly for cancers that are not sex specific. This article, the first in a series of two, summarizes the current burden, trends, risk factors, prevention, early detection, and survivorship of all cancers combined and seven sites (breast, cervix, uterine corpus, ovary, colorectum, lung, and liver) that account for about 60% of the cancer burden among women worldwide, using data from the International Agency for Research on Cancer. Estimated 2012 overall cancer death rates in general are higher among women in low- and middle-income countries (LMICs) than high-income countries (HICs), despite their lower overall incidence rates, largely due to inadequate access to early detection and treatment. For example, the top mortality rates are in Zimbabwe (147 deaths per 100,000) and Malawi (138). Furthermore, incidence rates of cancers associated with economic development (e.g., lung, breast, colorectum) are rising in several LMICs. The burden of cancer among women could be substantially reduced in both HICs and LMICs through broad and equitable implementation of effective interventions, including tobacco control, HPV and HBV vaccination, and screening (breast, cervix, and colorectum).

show abstract

“…34 Armed conflicts and migrations are making cancer care and cancer surveillance even more challenging, and have resulted in either the cessation of operations (eg, Benghazi, Libya, and Aden, Yemen) or the inability of long-established cancer registration systems, such as that in Iraq, to produce high-quality data. 9, 42,43 The protracted conflicts and an unprecedented number of 65•6 million forcibly displaced people worldwide, 44 imposes a need to develop mechanisms to extend cancer care and surveillance to both displaced and host populations. 45 In view of the widespread adoption of western lifestyles, and the projected rise in cancer due to population ageing and growth, the cost of inaction is high.…”

Section: Resultsmentioning

confidence: 99%

Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries

Znaor

Eser

Anton‐Culver

et al. 2018

The Lancet Oncology

View full text Add to dashboard Cite

The Global Initiative for Cancer Registry Development partnership, led by the International Agency for Research on Cancer (IARC), was established in response to an overwhelming need for high-quality cancer incidence data from low-income and middle-income countries. The IARC Regional Hub for cancer registration in North Africa, Central and West Asia was founded in 2013 to support capacity building for cancer registration in each of the countries in this region. In this Series paper, we advocate the necessity for tailored approaches to cancer registration given the rapidly changing cancer landscape for this region, and the challenges faced at a national level in developing data systems to help support this process given present disparities in resources and health infrastructure. In addition, we provide an overview of the status of cancer surveillance and activities country-by-country, documenting tailored approaches that are informing local cancer-control policy, and potentially curbing the growing cancer burden across the region.

show abstract

Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry

Cited by 31 publications

References 12 publications

The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment

The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment

Global Cancer in Women: Burden and Trends

Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries

Contact Info

Product

Resources

About